Stereotactic radiosurgery as a successful method to control meningeal metastatic adenoid cystic carcinoma of the lacrimal gland: A case report

Salim,Nidal; Libson,Evgeniy; Tumanova,Kristina; Krotenkova,Irina

doi:10.3892/mco.2022.2568

Stereotactic radiosurgery as a successful method to control meningeal metastatic adenoid cystic carcinoma of the lacrimal gland: A case report

Authors:
- Nidal Salim
- Evgeniy Libson
- Kristina Tumanova
- Irina Krotenkova
View Affiliations

Affiliations: Department of Radiation Oncology, European Medical Center, Moscow 129090, Russia, Department of Diagnostic Imaging, European Medical Center, Moscow 129090, Russia
Published online on: July 14, 2022 https://doi.org/10.3892/mco.2022.2568
Article Number: 135
Copyright: © Salim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adenoid cystic carcinoma (ACC) of the lacrimal gland is a rare tumor. In addition, considering the lack of data on large groups of patients there is no standard of care to treat patients with multiple meningeal metastases of ACC. A two‑year analysis of the course of the disease in a patient with synchronous oligometastatic ACC of the lacrimal gland that was treated with stereotactic radiosurgery (SRS) is presented. The aim of the present case report was to evaluate the effect of SRS in the treatment of a patient with ACC. Preliminary results confirmed that this method was highly effective in this patient. The patient is currently living with a good quality of life, normal vision and with no evidence of disease or complications. SRS exhibited reliable local tumor control and insignificant radiation‑related complications, rendering it an encouraging treatment option for patients with recurrent or metastatic ACC.

View Figures

View References

1	Tse DT, Benedetto P, Dubovy S, Schiffman JC and Feuer WJ: Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol. 141:44–53. 2006.PubMed/NCBI View Article : Google Scholar
2	Bernardini FP, Devoto MH and Croxatto JO: Epithelial tumors of the lacrimal gland: An update. Curr Opin Ophthalmol. 19:409–413. 2008.PubMed/NCBI View Article : Google Scholar
3	von Holstein SL, Fehr A, Persson M, Therkildsen MH, Prause JU, Heegaard S and Stenman G: Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics. Ophthalmology. 120:2130–2138. 2013.PubMed/NCBI View Article : Google Scholar
4	Sanders JC, Mendenhall WM and Werning JW: Adenoid cystic carcinoma of the lacrimal gland. Am J Otolaryngol. 37:144–147. 2016.PubMed/NCBI View Article : Google Scholar
5	Han J, Kim YD, Woo KI and Sobti D: Long-term outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland. Ophthalmic Plast Reconstr Surg. 34:74–78. 2018.PubMed/NCBI View Article : Google Scholar
6	Woo KI, Yeom A and Esmaeli B: Management of lacrimal gland carcinoma: Lessons from the literature in the past 40 years. Ophthalmic Plast Reconstr Surg. 32:1–10. 2016.PubMed/NCBI View Article : Google Scholar
7	Chae YK, Chung SY, Davis AA, Carneiro BA, Chandra S, Kaplan J, Kalyan A and Giles FJ: Adenoid cystic carcinoma: Current therapy and potential therapeutic advances based on genomic profiling. Oncotarget. 6:37117–37134. 2015.PubMed/NCBI View Article : Google Scholar
8	Mallen-St Clair J, Arshi A, Tajudeen B, Abemayor E and St John M: Epidemiology and treatment of lacrimal gland tumors: A population-based cohort analysis. JAMA Otolaryngol Head Neck Surg. 140:1110–1116. 2014.PubMed/NCBI View Article : Google Scholar
9	Lesueur P, Rapeaud E, Marzi LD, Goudjil F, Levy C, Galatoire O, Jacomet PV, Dendale R and Calugaru V: Adenoid cystic carcinoma of the lacrimal gland: High dose adjuvant proton therapy to improve patients outcomes. Front Oncol. 10(135)2020.PubMed/NCBI View Article : Google Scholar
10	Polanowski PA, Księżniak-Baran DA, Grządziel AB, Pietruszka A, Chmielik E, Pilecki B, Amrogowicz N, Gajda K and Składowski K: Successful treatment of adenoid cystic carcinoma with the application of a high-dose stereotactic body radiotherapy boost. Case Rep Oncol. 14:371–377. 2021.PubMed/NCBI View Article : Google Scholar
11	Wang CC and Goodman M: Photon irradiation of unresectable carcinomas of salivary glands. Int J Radiat Oncol Biol Phys. 21:569–576. 1991.PubMed/NCBI View Article : Google Scholar
12	Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW and Villaret DB: Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 26:154–162. 2004.PubMed/NCBI View Article : Google Scholar
13	Esmaeli B, Golio D, Kies M and DeMonte F: Surgical management of locally advanced adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg. 22:366–370. 2006.PubMed/NCBI View Article : Google Scholar
14	De Haan LD, De Mulder PH, Vermorken JB, Schornagel JH, Vermey A and Verweij J: Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck. Head Neck. 14:273–277. 1992.PubMed/NCBI View Article : Google Scholar
15	Papaspyrou G, Hoch S, Rinaldo A, Rodrigo JP, Takes RP, van Herpen C, Werner JA and Ferlito A: Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review. Head Neck. 33:905–911. 2011.PubMed/NCBI View Article : Google Scholar
16	Licitra L, Cavina R, Grandi C, Palma SD, Guzzo M, Demicheli R and Molinari R: Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann Oncol. 7:640–642. 1996.PubMed/NCBI View Article : Google Scholar
17	Laurie SA, Ho AL, Fury MG, Sherman E and Pfister DG: Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: A systematic review. Lancet Oncol. 12:815–824. 2011.PubMed/NCBI View Article : Google Scholar
18	Li J, Ludmire EB, Wang Y, et al: Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial. Lecture presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting, October 24-28, 2020.
19	Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, et al: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet. 363:1665–1672. 2004.PubMed/NCBI View Article : Google Scholar